Charac and Charac-Tol activated charcoal products

January 24, 2017

Health Canada is advising Canadians that four lots of activated charcoal products are being recalled by the company Omega Laboratories Ltd. because they may pose health risks. Children and people with weakened immune systems are at particular risk.

Health Canada updates Canadians on homeopathic teething products

October 20, 2016

Health Canada follows up with Canadians concerning the recent warning issued by the U.S. Food and Drug Administration (FDA) regarding possible safety issues involving homeopathic teething products in the United States.

Recommended Vaccines for Patients 50 Years of Age and Older

May 1, 2016

In general, adult Canadians are underimmunized for routine vaccine-preventable diseases. Primary responsibility for adult immunization falls to family doctors and other primary care providers. To streamline current recommendations for average Canadians, the following table is provided as a tool for everyday use.

Pfizer Consumer Healthcare recalling 124 lots of Advil liquid products for infants and children

May 1, 2016

Health Canada is informing Canadians that Pfizer Consumer Healthcare has initiated a voluntary recall of 124 lots of Advil liquid products for infants and children because of a potential risk of inconsistences in dosing of the product.

Ebola Resources from the ADA and CDC

May 1, 2016

The ADA Division of Science advises dental professionals not to treat dental patients if they have signs and symptoms of Ebola infection because most oral health providers do not have the appropriate equipment, experience and skills to treat safely an Ebola infected patient. Learn more: The CDC has produced an Ebola checklist for healthcare providers.

Gardasil vaccine safety studies show no new risks

December 11, 2015

After reviewing Canadian and international information regarding the safety of the HPV vaccine Gardasil, Health Canada is informing Canadians that the benefits of using this vaccine continue to outweigh the risks. The overall evidence continues to demonstrate that this vaccine can be safely used and that there are no new safety risks associated with its use.

Update by Sanofi Canada on Nationwide Voluntary Recall of Allerject

December 2, 2015

Following the October 28, 2015 voluntary recall by Sanofi-aventis Canada Inc. (Sanofi Canada) of all lots of Allerject® epinephrine auto-injectors of both the 0.15mg/0.15mL and 0.30mg/0.3mL strengths, and given the recent announcement that stock of alternative epinephrine auto-injectors is now sufficient to replace all Allerject® devices in Canada, Sanofi Canada is notifying the public of the following updates:

Sanofi Canada Issues Voluntary Nationwide Recall Of Allerject

October 28, 2015

Sanofi-aventis Canada Inc. (Sanofi Canada) is recalling all Allerject® (epinephrine injection, USP). The voluntary recall involves all Allerject currently on the market and includes both the 0.15 mg/ 0.15 mL and 0.3 mg/0.3 mL strengths for hospitals, retailers and consumers. The products have been found to potentially have inaccurate dosage delivery. If a patient who is experiencing a serious allergic reaction (i.e., anaphylaxis) did not receive the intended dose, there could be significant health consequences, including death because anaphylaxis is a potentially life-threatening condition.

Respiratory Syndrome (MERS)

April 16, 2014

MERS is viral respiratory illness first reported in Saudi Arabia in 2012.

Release of Antiviral Guidance for Avian Influenza A(H7N9) Virus

June 12, 2013

The Association of Medical Microbiology and Infectious Disease Canada (AMMI Canada) has developed guidance on the use of antiviral drugs for avian influenza A(H7N9) virus, to ensure that front-line clinicians have access to the required information should the novel virus emerge in Canada. This document can also be accessed via the Public Health Agency of Canada’s web site, under Emerging Respiratory Pathogens along with other avian influenza A(H7N9) virus and MERS CoV resources. Web links to the Agency and AMMI Canada web sites are provided below for your convenience.

AGRIFLU and FLUAD - Health Canada Lifts the Suspension of Distribution of these Seasonal Flu Vaccine

November 5, 2012

Novartis Pharmaceuticals Canada Inc., in collaboration with Health Canada, would like to inform you that the review of the safety information for AGRIFLU and FLUAD is now complete and Health Canada has released the two seasonal flu vaccines for immediate use.

Contaminated Kleenex-brand Hand Sanitizer Poses Serious Risk for People with Weakened Immune Systems

June 28, 2012

Kimberly-Clark Professional Corporation is voluntarily recalling Kleenex-brand Luxury Foam Hand Sanitizer due to microbial contamination. Product testing undertaken by the company detected bacteria that may pose serious health risks to people with weakened (compromised) immune systems, especially those with cystic fibrosis.

No causative link found between periodontal disease & heart disease

April 27, 2012

American Heart Assocation issues statement: No causative link found between periodontal disease & heart disease. The American Dental Association Council on Scientific Affairs agrees with the AHA’s conclusions in the statement. Via ADA News.

Supplementary information: JCDA article: Separating Fact from Fiction: Use of High-Level Evidence from Research Syntheses to Identify Diseases and Disorders Associated with Periodontal Disease.

Read the article

Benzocaine products

April 10, 2012

Health Canada is informing Canadians that it has requested companies to add new risk statements to the packaging and labelling of licensed benzocaine products.

Recall of ???Spinbrush Pro Clean SONIC Recharge Toothbrushes???: May Overheat and Cause Fire, Burn

April 10, 2012

Health Canada is advising Canadians that Church & Dwight Canada has initiated a voluntary recall of its "Spinbrush Pro Clean SONIC Recharge Toothbrushes" distributed in Canada and the U.S. The company has advised Health Canada that the recall is due to the risks, including fire, shock or burns posed by the charging base overheating. Document Français


April 3, 2012

Government official's statement announcing review results indicate Canadians can safely use toothpaste, shampoo and soap containing triclosan.

The Harper Government announced new measures

October 12, 2011

The Harper Government today announced new measures that will provide consumers with more information about energy drinks, to help ensure Canadian families make informed choices when it comes to these popular beverages.

Unlicensed HIV Home Test Kit: Accu-HIV 1 & 2 Saliva Test

September 12, 2011

Following information that a Toronto Company, ACCU-METRICS, has been advertising HIV home test kits for sale via their website, Health Canada would like to remind Canadians that there are currently no HIV test kits that have been authorized for home use in Canada.
For more information, click here

Health Canada is advising Canadians that Procter & Gamble is conducting a voluntary recall

July 14, 2011

Health Canada is advising Canadians that Procter & Gamble is conducting a voluntary recall of "Oral B Anti-Cavity Dental Rinse- Alcohol Free" (NPN 02129930) and "Oral-B Anti-Bacterial with Fluoride – Alcohol Free Daily Use Mouthrinse" (DIN 02130823).

Health Canada reminds Canadians of health risks associated with topical benzocaine products

April 19, 2011

Health Canada is reminding Canadians, including parents and caregivers, about health risks associated with the use of topical benzocaine products, including a rare but potentially serious blood condition known as methemoglobinemia (MetHb). Health Canada continues to receive reports of benzocaine-related adverse reactions, including MetHb. We continue to evaluate the safety of benzocaine products in light of these reports and will take appropriate regulatory actions as warranted.

Topical benzocaine products are available over-the-counter in various concentrations and formulations, including sprays, gels, liquids and creams, and are used to relieve pain from a variety of conditions such as sore throats, teething, toothache, canker sores, irritation of the mouth and gums, burns, insect bites, itching, and hemorrhoids. They are also used by healthcare practitioners during surgical, dental and other medical procedures to numb the mouth and throat.

RUSCH Irrigation Trays - Potential Contamination of Co-Packaged Alcohol Prep Pads - Teleflex Medical

April 15, 2011

Due to the potential bacterial contamination of certain lot numbers of Rusch Irrigation Tray co-packaged with Triad Alcohol Pads, Teleflex Medical is conducting a voluntary recall. Users should quarantine all products from the affected lot number immediately. For more information click here

GlaxoSmithKline issues consumer advisory

February 23, 2010

GlaxoSmithKline Consumer Healthcare issued a consumer advisory warning about the potential health risks associated with long-term excessive use of denture adhesives Poli-Grip ‘Advanced Care’, ‘Extra Strength’ and ‘Ultra Fresh’.

Recall of one lot of Rofact (rifampin) 300 mg due to labeling error

May 22, 2009

One lot of Rofact (rifampin) DIN 00343617, manufactured by Valeant Canada, is being recalled to the retail level. Some bottles of the lot 8K5467 may contain the drug clonazepam instead of the antibiotic rifampin.

Medical Device Recall -Warning Label Addition / Silver Care Toothbrushes and Silver Care Toothbrush

April 30, 2009

Norwex Enviro Products Inc. issued a letter to notify customers of safety information regarding Silver Care Toothbrushes and Silver Care Toothbrush refills and their intention to correct the affected products. The device may pose a possible choking or swallowing hazard for individuals requiring assistance brushing their teeth.

Topical Anesthetics with Serious Side Effects

March 6, 2009

Health Canada, in collaboration with AstraZeneca Canada Inc. and Smith & Nephew Inc., is warning Canadians about the potential hazards of topical anesthetics (e.g. EMLA®, AMETOP Gel™ and locally compounded products). Topical anesthetics are generally approved for numbing the skin before procedures like vaccinations and minor skin surgery. Topical anesthetics are also being used, often without direct medical supervision, to numb large areas of skin before cosmetic procedures such as laser removal of body hair. In recent years there have been reports of serious adverse events including fatalities that have been associated with excessive topical application of local anesthetics in both adult and pediatric patients. Other side effects reported with the use of topical anesthetics also include seizures, irregular heartbeat and difficulty breathing.

Beware Counterfeit Toothbrushes

February 17, 2009

Health Canada is advising Canadian consumers and retailers to exercise caution when purchasing toothbrushes. Counterfeit toothbrushes falsely labelled as Colgate Massager, Colgate Navigator, Oral B Classic 40, Oral B Contura and Colgate 360.